ITP and thrombosis: an intriguing association

Abstract

In the last decade, after the initial reports of thrombotic events in patients exposed to the thrombopoietin-receptor agonists (TPO-RA) romiplostim and eltrombopag, large epidemiological investigations have been conducted to establish if increased thrombotic risk could be a hitherto unknown feature